NTES BLUECHIP_DIP Signal

BUY BLUECHIP_DIP Stopped out Bluechip · 1.00%
Media · OUTPERFORM · Bull Market · BLUECHIP_DIP
★★★★★
6/7 Quality
Entry
$119.90
Stop Loss
$101.92
TP1
$148.68
TP2
$149.64
R:R
1.60

Analyst vs AI Verdict

ALIGNED
Wall Street
91.2% Buy Rating
10
Str.Buy
21
Buy
3
Hold
0
Sell
0
Str.Sell
34 analysts · Sept. 1, 2026
AI Expert Panel
STRONG_BUY
ChatGPT BUY
Claude BUY
Grok BUY
Gemini BUY

Price Chart

Entry Reason

Drawdown 25% (within range) | Price < SMA50 (short-term dip) | Significant drawdown 25% | Price < SMA100 | Price < SMA200 (deep dip) | RSI oversold (44) | RSI turning up (43 → 44)

Entry Technical Conditions

Methodology →
RSI
44.3
Neutral
ADX
18.1
Weak
Volume
0.12x
Low
BB Pos
0.25
Mid
ATR %
2.8%
Normal

AI Expert Panel

STRONG_BUY
ChatGPT BUY ✗ Wrong

Price action: NTES is around $119.90 after a multi-month pullback from the 150–160 zone, sitting near a defined support area (roughly 110–125). A break above the mid-120s on strong volume would confirm fresh upward momentum; the current price can be viewed as a dip-entry with potential for a quick bounce if buyers step in. Fundamentals: NTES shows solid profitability and balance sheet metrics (ROE 21.6%, net margin 29.8%, gross margin 65.7%), modestly valued (P/E 15.5, P/B 3.67) with a low beta (0.69), supporting downside protection and upside optionality in a swing window. Key risks: Chinese regulatory/regulatory risk for tech/gaming, macro headwinds, competitive pressure, and potential volatility around earnings or licensing news could cap gains in the 2-12 week horizon. Final verdict and upside: if momentum returns, a move back toward the 140-145 area over the next 6-10 weeks implies roughly 15-20% upside; there is further potential toward 150-160 if positive catalysts persist; use a tight stop around 112-115 to manage risk.

Claude BUY ✗ Wrong

NTES is trading at $119.90, near a 52-week low of $115.02 (Feb 2026), representing a compelling entry point after a significant 23% decline from the $155.27 peak in September 2025. The fundamental health remains solid with a P/E of 15.5, strong ROE of 21.6%, excellent net margin of 29.8%, and a healthy current ratio of 3.28, indicating the company is not in distress despite recent price weakness. Recent analyst activity (Morgan Stanley price target lift) suggests institutional confidence, and the stock shows technical support around the $115-120 level with multiple bounces, indicating potential for mean reversion toward $130-135 within the 2-12 week window. Key risks include the media/gaming sector's cyclicality, China regulatory concerns affecting NetEase's operations, and the stock's recent volatility (high volume spikes), but the 15-20% upside to recent resistance levels ($135-140) offers an attractive risk-reward ratio for a swing trade, with a stop-loss below $115 limiting downside exposure.

Grok BUY ✗ Wrong

Price action shows NTES trading near multi-month lows around $119-120 after declining from $155 levels in late 2025, creating a potential dip-buy entry point with recent stabilization and analyst support from Morgan Stanley raising its price target. Fundamentals are healthy with strong ROE of 21.6%, net margins near 30%, a robust current ratio of 3.28, and a reasonable P/E of 15.5, supporting resilience in the media sector despite modest revenue growth. Key risks over 2-12 weeks include China regulatory pressures on gaming/content, broader market volatility given its beta of 0.69, and potential earnings misses that could extend the downtrend. Overall verdict is BUY with estimated 12-18% upside potential to $135-142 as momentum builds on the analyst upgrade and any rebound from current support levels.

Gemini BUY ✗ Wrong

NetEase is currently trading at $119.90, which sits near the lower end of its recent trading range, offering a favorable risk-to-reward entry point for a short-term swing. The company maintains strong fundamental health with a solid 21.6% ROE and a healthy net margin of 29.8%, suggesting it is well-positioned to capitalize on market volatility. While the stock has faced recent downward pressure, the recent analyst upgrade from Morgan Stanley provides a positive sentiment catalyst that could drive a recovery toward the $130 resistance level. Key risks over the 2-12 week horizon include broader market volatility and potential regulatory shifts in the Chinese tech sector, but the current valuation at a 15.5 P/E ratio appears attractive for a potential 8-10% upside move.

Fundamentals Trend

Metric 2025-10-022025-11-032025-12-032026-01-022026-05-212026-08-20
ROE (TTM) 24.2%24.2%24.7%24.7%22.1%21.6%
P/E (TTM) 19.4417.8417.0616.3114.4815.55
Net Margin 31.2%31.2%32.5%32.5%30.0%29.8%
Gross Margin 63.2%63.2%63.5%63.5%64.3%65.7%
D/E Ratio 7.547.544.704.70——
Current Ratio 3.233.233.423.423.453.28

More Signals for NTES

View all →

Related News

View all →

Disclaimer: This is an automated trading signal generated by AI analysis. It is not financial advice. Always do your own research before making investment decisions. Past performance does not guarantee future results.